Literature DB >> 7751461

Neurocutaneous syndromes associated with pigmentary skin lesions.

A Zvulunov1, N B Esterly.   

Abstract

Tremendous strides have been made in our understanding of genetic disorders, including those that involve both the skin and the nervous system. The list of well-established neurocutaneous syndromes has increased during a few decades from a few classical phakomatoses to more than 30 entities. The dermatologist has the opportunity to facilitate precise diagnosis and optimal care for these patients by recognition of the cutaneous markers for these diseases. We have attempted to provide an overview of some recent advances in those syndromes manifested by pigmentary skin changes, emphasizing the clinical spectrum of each disorder and providing guidelines for an approach to management.

Entities:  

Mesh:

Year:  1995        PMID: 7751461     DOI: 10.1016/0190-9622(95)91325-4

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues.

Authors:  R Wienecke; J C Maize; J A Reed; J de Gunzburg; R S Yeung; J E DeClue
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

2.  The occurrence of cutaneous nerve endings and neuropeptides in vitiligo vulgaris: a case-control study.

Authors:  P Y Liu; L Bondesson; W Löntz; O Johansson
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

3.  Aberrant axon neurofilaments in schwannomas associated with phacomatoses.

Authors:  Janine Wechsler; Laurent Lantieri; Jacques Zeller; Marie-Catherine Voisin; Nadine Martin-Garcia; Pierre Wolkenstein
Journal:  Virchows Arch       Date:  2003-09-24       Impact factor: 4.064

4.  Neuropeptides Profile and Increased Innervation in Becker's Nevus.

Authors:  Ji Seok Kim; Myeong Jin Park; Hye Young Kang; Seung Phil Hong; Byung Cheol Park; Myung Hwa Kim
Journal:  Ann Dermatol       Date:  2019-02-28       Impact factor: 1.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.